Nonepithelial ovarian cancer: Outcomes after aggressive treatment with surgery and platinum-based chemotherapy.

被引：1
|
作者：
Machado, K. K.
Nebuloni, D. R.
Estevez-Diz, M. D.
Castro, G., Jr.
Hoff, P. M.
机构：
[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e15548
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15548
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy
    Matsumoto, Aya
    Higuchi, Toshihiro
    Yura, Shigeo
    Mandai, Masaki
    Kariya, Masatoshi
    Takakura, Kenji
    Fujii, Shingo
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2006, 32 (06) : 580 - 587
  • [2] Real world outcomes for maintenance avelumab treatment in locally advanced/metastatic urothelial cancer after platinum-based chemotherapy.
    Rehan, Ahmed
    Qureshi, Muneeb
    Aydin, Sabin Goktas
    O'Connor, Kate
    Serra, Maria
    Charnley, Natalie
    Spurgeon, Laura
    Muazzam, Iqtedar
    Bansal, Vikram
    Vasudev, Naveen
    Coe, Faye
    Kagzi, Mohammed Mubashir
    Din, Omar
    Leach, Diane
    Hubbard, Rachel
    Catto, James W. F.
    Hussain, Syed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [3] Risk of leukemia after platinum-based chemotherapy for ovarian cancer
    Travis, LB
    Holowaty, EJ
    Bergfeldt, K
    Lynch, CF
    Kohler, BA
    Wiklund, T
    Curtis, RE
    Hall, P
    Andersson, M
    Pukkala, E
    Sturgeon, J
    Stovall, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (05): : 351 - 357
  • [4] BEVACIZUMAB AND PLATINUM-BASED CHEMOTHERAPY IN RELAPSED OVARIAN CANCER TREATMENT
    Davidenko, I.
    Kazantseva, M.
    Porhanova, N.
    Potemin, S.
    Oganyan, M.
    Syrota, L.
    Shmatkova, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [5] Impact of epoetin beta on the survival of anemic patients with ovarian cancer receiving platinum-based chemotherapy.
    Reed, N
    Chan, S
    Hayward, C
    Burger, HU
    Huinink, WT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 479S - 479S
  • [6] Chemotherapy with doxorubicin, etoposide and cyclophosphamide (DEC) in ovarian cancer persistent after platinum-based treatment
    Zanetta, G
    LoMonico, S
    Gabriele, A
    Miceli, D
    Mangioni, C
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) : 178 - 179
  • [7] Rationale for the combination of veliparib with platinum-based chemotherapy.
    Maag, David
    Solomon, Larry
    Hopkins, Todd
    Bukhofzer, Gail
    Shi, Yan
    Donawho, Cherrie
    Zhu, Gui-Dong
    Rodriguez, Luis E.
    Penning, Thomas
    DiGiammarino, Enrico
    Panchal, Sanjay C.
    Johnson, Eric Feral
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer
    Markman, Maurie
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 273 - 274
  • [9] Pembrolizumab after platinum-based chemotherapy for treatment of metastatic bladder cancer
    Richters, A.
    Van der Heijden, A. G.
    Mehra, N.
    Meijer, R. P.
    Kiemeney, L. A.
    Boormans, J. L.
    Aben, K.
    EUROPEAN UROLOGY, 2024, 85 : S1728 - S1728
  • [10] Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer
    Yang, Ling
    Xie, Hong-Jian
    Li, Ying-Ying
    Wang, Xia
    Liu, Xing-Xin
    Mai, Jia
    ONCOLOGY REPORTS, 2022, 47 (04)
12345